Research Power Inc. recently contributed to two hematology engagements in Rio de Janeiro, Brazil, led by Senior Partner Claudine Szpilfogel.
Claudine was invited to facilitate a hematology advisory board focused on understanding the factors that inform treatment decisions in chronic lymphocytic leukemia (CLL). This marked the first time the organizing team engaged an external facilitator, a role traditionally managed by its medical team.
During the same visit, Claudine also presented at the annual Brazilian hematology congress, exploring how clinical data can inform patient-centred treatment decisions, alongside two leading Brazilian hematologists.
Both engagements highlight RPI’s expertise in advisory board facilitation, clinical data interpretation and scientific communication.
The presentation explored four considerations in interpreting clinical research: quality, maturity, consistency and clinical relevance, with a focus on how these inform patient-centred treatment decisions.